Home › Kidney Diseases › Colorado › Denver
Kidney Diseases clinical trials in Denver, CO
5 studies for Kidney Diseases are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
NightWare and Cardiovascular Health in Women With PTSD
RecruitingHealthy volunteers welcome
- University of Colorado CCTSI CTRC, Denver
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
- Jade Clinical Site, Denver
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Colorado Kidney Care Nephrology, Denver
NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recruiting
- Denver Health and Hospital Authority, Denver
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- University of Colorado Anschutz Medical Campus, Denver
- Denver Nephrology Research Division, Denver
About Kidney Diseases
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
More about Kidney Diseases on MedlinePlus
Kidney Diseases trials in other cities
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- Philadelphia, PA5 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Durham, NC5 studies
- New York City, NY5 studies
- Winston-Salem, NC4 studies
- San Francisco, CA4 studies
- Los Angeles, CA4 studies
Other studies in Denver
- Breast Cancer26 studies
- Multiple Myeloma26 studies
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer25 studies
- Colorectal Cancer22 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Cancer (all types)15 studies
- Lung Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.